The clinical history and costs associated with delayed diagnosis of bipolar disorder

MedGenMed Medscape General Medicine

Volumn 8, Issue 2, 2006, Pages

  Stang, Paul E ^a,b   Frank, Cathy ^c   Kalsekar, Anupama ^d,e   Yood, Marianne Ulcickas ^b,c,f   Wells, Karen ^c   Burch, Steven ^e  

^a WEST CHESTER UNIVERSITY   (United States)

^b Galt Associates   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d GlaxoSmithKline ^*

^e GLAXOSMITHKLINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGE; AGED; ARTICLE; BIPOLAR DISORDER; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; DATA ANALYSIS; EMERGENCY WARD; FEMALE; GENDER; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MENTAL HEALTH CARE; OUTPATIENT CARE; PHARMACY; POPULATION RESEARCH; PSYCHIATRIC DIAGNOSIS; RACE; ADOLESCENT; COST; ECONOMICS; MIDDLE AGED; RETROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33645893750     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1 year prevalence rates of disorders and services. Arch Gen Psychiatry. 1993;50:85-94.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
3. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143-151.
4. Hirschfeld RM. Bipolar spectrum disorder: improving its recognition and diagnosis. J Clin Psychiatry. 2001;62:5-9.
5. Judd LL. Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: a re-analysis of the ECA database taking into account subthreshold cases. J Affective Disord. 2003;73:123-131.
6. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness: 1991. Social Psychiatry Psychiatr Epidemiol. 1995;30:213-219.
7. Fu AZ, Krishnan AA, Harris SD, et al. The economic burden of bipolar-related phases of depression versus mania. Drug Benefit Trends. 2004;16:569-575.
8. Simon GE, Unützer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatric Services. 1999;50:1303-1308.
9. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord. 2002;4:398-405.
10. Hirschfeld RMA, Lewis L, Vornick LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000-survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161-174.
11. Ghaemi SN, Sachs GS, Chiou AM, et al. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affective Disord. 1999;52:135-144.
12. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry. 2000;61:804-808.
13. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic depressive cycle and changes caused by treatments. Pharmakopsychiatrie Neuro-Psychopharmakologie. 1980;13:156-167.
14. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995;152:1130-1138.
15. Goodwin FK, Jamison KR. Manic Depressive Illness. New York: Oxford University Press, 1990.
16. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987;144:1403-1411.
17. Perugi C, Micheli C, Akiskal HS, et al. Polarity of the first episode, clinical characteristics, and course of manic-depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Comp Psychiatry. 2000;41:13-18.
18. Birnbaum HG, Shi L, Dial E, et al. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. J Clin Psychiatry. 2003;64:1201-1209.
19. Russell J, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant deppression. J Clin Psychiatry. 2004;65:341-347.
20. Unützer J, Simon GE, Pabiniak C, et al. The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. Gen Hosp Psychiatry. 2000;22:1-10.